Anavex Life Sciences Corp (AVXL)

[falconer66a]

Potential AVXL Outcomes

What comes out of the entire exercise is that AVXL is one of the few stocks that can really have an enormously wide group of possible outcomes, with lots of great possibilities.

Exactly.

At the lowest input numbers, the lowest being disapproval by the FDA, buying or holding a few dozen AVXLs is not advisable.

Not the case, however, if the FDA approves blarcamesine for any one of these: Rett syndrome (smallish returns), Parkinson's disease dementia (rather rewarding returns), and then the biggie, Alzheimer's (unbelievable outcomes).

I've got some more funds available in my family budget discretionary funds category. Right now, I'm going to hold my current AVXL position to the end, good or bad (have the greatest confidence it will be good, very good). But when Rett results appear, and they are all positive (very likely the case), I'll make my final AVXL buys, depleting the discretionary funds in my budget.

I enjoy reading trading poster's accounts of their trades, making a few dollars with each. Glad that dollars can be made that way. On paper, I tried it for a few months; but failed. Understanding of the deep and unique Anavex science is my thing, which I've used to determine the very high likelihoods of blarcamesine success. That, for me, has required long-term perspectives, year after year, out (now) to 2023. I'm ever more confident in the involved science, and with the projections of my spreadsheet. I'm very pleased and confident of my existing AVXL position. Things happening this year, finally, will decide its fate.